Protocol for morphogen-guided differentiation of brain cell types using human induced pluripotent stem cells.

Area of Science:

• Neuroscience
• Stem Cell Biology
• Genomics

Background:

• Modeling neurological disorders presents challenges due to interspecies variations in functional genomics and phenotypes.
• Accurate human cell models are crucial for understanding complex brain disorders.

Purpose of the Study:

• To present a detailed protocol for morphogen-guided differentiation of human induced pluripotent stem cells (hiPSCs).
• To generate specific neural cell types, including microglia, astrocytes, and mixed cortical cultures (MCCs), for disease modeling.
• To enable cell-type-specific investigations into human brain disorders and facilitate drug screening.

Main Methods:

• Utilizing morphogen gradients for directed differentiation of hiPSCs.
• Implementing hypoxia to enhance microglial production.
• Establishing quality-control measures for astrocyte and MCC differentiations.
• Describing knockout serum replacement for generating serum-free astrocytes.

Main Results:

• Successful differentiation of hiPSCs into microglia, astrocytes, and MCCs.
• Enhanced yield of microglia through hypoxic conditions.
• Validated quality-control methods ensuring reliable cell cultures.
• Demonstrated protocol for serum-free astrocyte generation.

Conclusions:

• The developed protocol provides a robust method for generating specific human neural cell types from hiPSCs.
• This approach facilitates the study of human-specific disease mechanisms in neurological disorders.
• The protocol supports high-throughput drug screening and personalized medicine applications in neuroscience.